Aspirin 81 mg
Aspirin 81 mg is a pharmaceutical drug with 26 clinical trials. Currently 3 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
7
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
70.6%
12 of 17 finished
29.4%
5 ended early
3
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Aspirin and Preeclampsia
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
Timed Aspirin Chronobiome Study
Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)
Clinical Trials (26)
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Aspirin and Preeclampsia
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
Timed Aspirin Chronobiome Study
Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)
Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
Chronic Kidney Disease (CKD) Platelet Study
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations
COMT on Aspirin Platelets Effects (CAPE)
Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
Aspirin for Prevention of Preeclampsia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 26